Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent Adjei AAClin Cancer Res 2004[Jun]; 10 (12 Pt 2): 4276s-4280sPemetrexed (ALIMTA, LY231514, MTA) is a novel antimetabolite that inhibits at least three enzymes involved in the folate pathway. These enzymes are thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. Pemetrexed has demonstrated clinical activity in non-small cell lung cancer as well as in a broad array of other solid tumors, including mesothelioma, breast, colorectal, bladder, cervical, gastric and pancreatic cancer. In non-small cell lung cancer, single-agent activity has been documented in the first- and second-line settings in Phase II and Phase III trials. Promising activity has also been demonstrated when pemetrexed is combined with platinum compounds (cisplatin, carboplatin, and oxaliplatin), vinorelbine, and gemcitabine. Low level dietary supplement of folic acid and vitamin B12 has significantly decreased the mucosal and bone marrow toxicity of pemetrexed without compromising its antitumor effect.|Antineoplastic Agents/administration & dosage/adverse effects/*pharmacology[MESH]|Antineoplastic Combined Chemotherapy Protocols/therapeutic use[MESH]|Carcinoma, Non-Small-Cell Lung/*drug therapy[MESH]|Clinical Trials as Topic[MESH]|Folic Acid/administration & dosage[MESH]|Glutamates/administration & dosage/adverse effects/*pharmacology[MESH]|Guanine/administration & dosage/adverse effects/*analogs & derivatives/*pharmacology[MESH]|Humans[MESH]|Lung Neoplasms/*drug therapy[MESH]|Neoplasms/drug therapy[MESH]|Pemetrexed[MESH]|Platinum Compounds/therapeutic use[MESH]|Thymidylate Synthase/antagonists & inhibitors[MESH]|Vitamin B 12/administration & dosage[MESH] |
